Skip to main content

Advertisement

Log in

Retinoic acid inhibition of Epstein-Barr virus induction

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

TUMOUR promoters of the diterpene type efficiently induce Epstein-Barr virus (EBV) and additional persisting herpes viruses in genome-harbouring lymphatic cells1,2. The tumour-promoting activity of these substances to some extent parallels their efficiency in virus induction2: the most active tumour promoters induce EBV even at concentrations of 10−10–10−9 M, whereas 100–500-fold higher concentrations are required for induction by weak promoters. Treatment of cells with tumour promoters results in a fast and reproducible increase in the activity of ornithine decarboxylase (ODC)3,4 up to 250-fold levels of normal activity. Recent reports5,6 described the inhibition of ODC induction by pretreating the cells with retinoic acid. Moreover, retinoic acid has been reported to act as an inhibitor in experimental 2-stage carcinogenesis models7. We have therefore investigated the possible interaction of retinoic acid with virus induction by tumour promoters. The effect of retinoic acid was also studied on the induction of early antigens (EA) of EBV by the pyrimidine analogue, iododeoxyuridine (lUdR)8,9, by treatment of IgM- producing cells with anti-IgM antibodies10 and by superinfection with EBV from P3HR-1 cells11,12. The data indicate that retinoic acid specifically interferes with induction by non-viral reagents without affecting EBV antigen synthesis after superinfection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. zur Hausen, H., O'Neill, F., Freese, U.-K. & Hecker, E. Nature 272, 373–375 (1978).

    Article  ADS  CAS  Google Scholar 

  2. zur Hausen, H., Bornkamm, G. W., Schmidt, R. & Hecker, E. Proc. natn. Acad. Sci. U.S.A.(in the press).

  3. O'Brien, T. G., Simsiman, R. C. & Boutwell, R. K. Cancer Res. 35, 2426–2433 (1975).

    CAS  PubMed  Google Scholar 

  4. O'Brien, T. G. Cancer Res. 36, 2644–2653 (1976).

    CAS  PubMed  Google Scholar 

  5. Verma, A. K. & Boutwell, R. K. Cancer Res. 37, 2196–2201 (1977).

    CAS  PubMed  Google Scholar 

  6. Kensler, T. W., Verma, A. K., Boutwell, R. K. & Mueller, G. C. Cancer Res. 38, 2896–2899 (1978).

    CAS  PubMed  Google Scholar 

  7. Shamberger, R. J. J. natn. Cancer Inst. 47, 667–673 (1971).

    CAS  Google Scholar 

  8. Hampar, B., Derge, J. G., Martos, L. M. & Walker, G. L. Proc. natn. Acad. Sci. U.S.A. 69, 78–82 (1972).

    Article  ADS  CAS  Google Scholar 

  9. Gerber, P. Proc. natn. Acad. Sci. U.S.A. 69, 83–85 (1972).

    Article  ADS  CAS  Google Scholar 

  10. Tovey, M. G., Lenoir, G. & Begon-Lours Nature 276, 270–272 (1978).

    Article  ADS  CAS  Google Scholar 

  11. Henle, W. et al. Science 169, 188–190 (1970).

    Article  ADS  CAS  Google Scholar 

  12. Henle, G., Henle, W. & Klein, G. Int. J. Cancer 8, 272–282 (1971).

    Article  CAS  Google Scholar 

  13. Tabor, H. & Tabor, C. W. J. biol. Chem. 244, 2286–2292 (1969).

    CAS  PubMed  Google Scholar 

  14. Tabor, C. W. & Tabor, H. A. Rev. Biochem. 45, 282–206 (1976).

  15. O'Brien, T. G., Simsiman, R. C. & Boutwell, R. K. Cancer Res. 36, 3766–3770 (1976).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

YAMAMOTO, N., BISTER, K. & HAUSEN, H. Retinoic acid inhibition of Epstein-Barr virus induction. Nature 278, 553–554 (1979). https://doi.org/10.1038/278553a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/278553a0

  • Springer Nature Limited

This article is cited by

Navigation